Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
First Tracks Biotherapeutics, Inc. (TRAX) had Income from Continuous Operations of -50.48M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-50.48M |
|
-- |
|
-- |
|
52.81M |
|
-52.81M |
|
2.33M |
|
-50.48M |
|
-50.48M |
|
-50.48M |
|
|
Income from Continuous Operations |
-50.48M |
-50.48M |
|
-50.48M |
|
-52.81M |
|
-52.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
289.40M |
|
1.17M |
|
1.17M |
|
290.58M |
|
33.11M |
|
-- |
|
-- |
|
33.11M |
|
257.46M |
|
257.46M |
|
257.46M |
|
-- |
|
| Cash Flow Statement Financials | |
-32.56M |
|
34.98M |
|
7.85M |
|
238.20M |
|
248.47M |
|
10.27M |
|
11.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.61% |
|
-19.61% |
|
-17.37% |
|
-19.61% |
|
-- |
|
-- |
|
-- |
|